{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:25:54Z","timestamp":1780676754877,"version":"3.54.1"},"reference-count":4,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,20]]},"DOI":"10.7759\/cureus.60701","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T21:01:08Z","timestamp":1716238868000},"source":"Crossref","is-referenced-by-count":2,"title":["The Rare Adverse Effect of Myalgia After Dupilumab Biologic Therapy for Refractory Atopic Dermatitis"],"prefix":"10.7759","author":[{"given":"Brigitte  L","family":"Cochran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R","family":"Raymond-Lezman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Coican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Sagasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutva","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Batrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda F","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1582403","article-title":"A review of dupilumab in the treatment of atopic diseases","volume":"15","author":"Thibodeaux Q","year":"2019","unstructured":"Thibodeaux Q, Smith MP, Ly K, Beck K, Liao W, Bhutani T. A review of dupilumab in the treatment of atopic diseases. Hum Vaccin Immunother. 2019, 15:2129-39. 10.1080\/21645515.2019.1582403","journal-title":"Hum Vaccin Immunother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.025","article-title":"Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: a US nationwide cohort study","volume":"90","author":"Schneeweiss MC","year":"2024","unstructured":"Schneeweiss MC, Wyss R, Schneeweiss S, et al.. Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: a US nationwide cohort study. J Am Acad Dermatol. 2024, 90:134-7. 10.1016\/j.jaad.2023.08.025","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.42558","article-title":"Characterization of a musculoskeletal syndrome of enthesitis and arthritis in patients with atopic dermatitis treated with dupilumab, an interleukin-4\/13 inhibitor","volume":"75","author":"Hughes CD","year":"2023","unstructured":"Hughes CD, Nathan J, Mathew L, et al.. Characterization of a musculoskeletal syndrome of enthesitis and arthritis in patients with atopic dermatitis treated with dupilumab, an interleukin-4\/13 inhibitor. Arthritis Rheumatol. 2023, 75:1793-7. 10.1002\/art.42558","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7565","article-title":"Dupilumab for atopic dermatitis: the silver bullet we have been searching for?","volume":"12","author":"Tameez Ud Din A","year":"2020","unstructured":"Tameez Ud Din A, Malik I, Arshad D, Tameez Ud Din A. Dupilumab for atopic dermatitis: the silver bullet we have been searching for?. Cureus. 2020, 12:e7565. 10.7759\/cureus.7565","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256456-the-rare-adverse-effect-of-myalgia-after-dupilumab-biologic-therapy-for-refractory-atopic-dermatitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T21:01:11Z","timestamp":1716238871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256456-the-rare-adverse-effect-of-myalgia-after-dupilumab-biologic-therapy-for-refractory-atopic-dermatitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":4,"URL":"https:\/\/doi.org\/10.7759\/cureus.60701","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,20]]}}}